Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Habib Fakhrai
CD24+/CD38- As New Prognostic Marker for Non-Small Cell Lung Cancer
Multidisciplinary Respiratory Medicine
Pulmonary
Respiratory Medicine
Related publications
Serum Pleiotrophin as a Diagnostic and Prognostic Marker for Small Cell Lung Cancer
Journal of Cellular and Molecular Medicine
Molecular Medicine
Cell Biology
Prognostic Gene Signatures for Non-Small-Cell Lung Cancer
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
A Meta-Analysis for CXCR4 as a Prognostic Marker and Potential Drug Target in Non-Small Cell Lung Cancer
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
P3.16-01 a Multi-Omic Study Reveals BTG2 as a Reliable Prognostic Marker for Early-Stage Non-Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Prognostic Significance of CD276 in Non-Small Cell Lung Cancer
Open Medicine (Poland)
Medicine
New Strategies in Lung Cancer: Epigenetic Therapy for Non-Small Cell Lung Cancer
Clinical Cancer Research
Cancer Research
Oncology
Value of the Glasgow Prognostic Score as a Prognostic Factor in Resectable Non–Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Circulating Tumor Cells as a Screening and Diagnostic Marker for Early-Stage Non-Small Cell Lung Cancer
OncoTargets and Therapy
Oncology
Pharmacology
Prognostic Significance of FoxM1 Expression in Non-Small Cell Lung Cancer
Journal of Thoracic Disease
Pulmonary
Respiratory Medicine